Cancer-associated retinopathy presenting as retinal vasculitis with a negative ERG suggestive of on-bipolar cell pathway dysfunction

Documenta Ophthalmologica

Volumn 123, Issue 1, 2011, Pages 59-63

  Anastasakis, Anastasios ^a   Dick, Andrew D ^a   Damato, Erika M ^a   Spry, Paul G ^a   Majid, Mohamed A ^a  

^a BRISTOL EYE HOSPITAL   (United Kingdom)

Author keywords

Breast carcinoma; Cancer associated retinopathy; Electronegative ERG; On bipolar cell pathway dysfunction; Retinal vasculitis

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER ASSOCIATED RETINOPATHY; CANCER CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; ELECTRORETINOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; INTRAOCULAR PRESSURE; LUNG TUMOR; MELANOMA; METASTASIS; PANCREAS TUMOR; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; RETINA BIPOLAR GANGLION CELL; RETINA VASCULITIS; RETINOPATHY; TUMOR BIOPSY; VISUAL ACUITY;

ANTINEOPLASTIC AGENTS; BIOPSY; BREAST NEOPLASMS; CARCINOMA, LOBULAR; ELECTRORETINOGRAPHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; PANCREATIC NEOPLASMS; PARANEOPLASTIC SYNDROMES; RETINAL BIPOLAR CELLS; RETINAL VASCULITIS; TOMOGRAPHY, X-RAY COMPUTED; VISUAL ACUITY; VISUAL PATHWAYS;

EID: 79960899593     PISSN: 00124486     EISSN: 15732622     Source Type: Journal    
DOI: 10.1007/s10633-011-9277-y     Document Type: Article

References (14)

1. Sawyer RA, Selhorst JB, Zimmerman LE, Hoyt WF (1976) Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol 81:606-613
2. Khan N, Huang JJ, Foster CS (2006) Cancer associated retinopathy (CAR): an autoimmune-mediated paraneoplastic syndrome. Semin Ophthalmol 21:135-141 (Pubitemid 44266787)
3. Maeda T, Maeda A, Maruyama I, Ogawa K, Kuroki Y, Sahara H, Sato N, Ohguro H (2001) Mechanisms of photoreceptor cell death in cancer-associated retinopathy. Invest Ophthalmol Vis Sci 42(3):705-712 (Pubitemid 32206912)
4. Robertson DM (2002) Non-cancerous ophthalmic clues to non-ocular cancer. Surv Ophthalmol 47(5):397-430
5. Matsui Y, Mehta MC, Katsumi O, Brodie SE, Hirose T (1992) Electrophysiological findings in paraneoplastic retinopathy. Graefes Arch Clin Exp Ophthalmol 230:324-328
6. Audo I, Robson AG, Holder GE, Moore AT (2008) The negative ERG: clinical phenotypes and disease. Mechanisms of inner retinal dysfunction. Surv Ophthalmol 53:16-40
7. Koh AH, Hogg CR, Holder GE (2001) The incidence of negative ERG in clinical practice. Doc Ophthalmol 102:19-30 (Pubitemid 32618792)
8. Lei B, Bush RA, Milam AH, Sieving PA (2000) Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo. Invest Ophthalmol Vis Sci 41:262-266 (Pubitemid 30036576)
9. Alexander KA, Barnes CS, Fishman GA, Milam AH (2002) Nature of the cone on- pathway dysfunction in melanoma associated retinopathy. Invest Ophthalmol Vis Sc 43(4):1189-1197 (Pubitemid 34258292)
10. Goetgebuer G, Kestelyn-Stevens AM, De Laey JJ, Kestelyn P, Leroy BP (2008) Cancer-associated retinopathy (CAR) with electronegative ERG: a case report. Doc Ophthalmol 116:49-55 (Pubitemid 351167831)
11. Kim SJ, Toma HS, Thirkill CE, Dunn JP (2010) Cancer-associated retinopathy with retinal periphlebitis in a patient with ovarian cancer. Ocul Immunol Inflamm 18(2):107-109
12. Ing EB, Younge BR, Leavitt JA, Lee RA, Bostwick DG (1995) Paraneoplastic retinopathy and gynecologic malignancy. J Pelvic Surg 1:79-83
13. Rizzo JF, Gittinger JW (1992) Selective immunohistochemical staining in the paraneoplastic retinopathy syndrome. Ophthalmology 99:1286-1295
14. Cao R, Cao Y (2010) Cancer-associated retinopathy: a new mechanism insight on vascular remodeling. Cell Cycle 9(10):1882-1885